Evaluating multiple sclerosis severity loci 30 years after a clinically isolated syndrome

Abstract The first genome-wide significant multiple sclerosis severity locus, rs10191329, has been pathologically linked to cortical lesion load and brain atrophy. However, observational cohorts such as MSBase have not replicated associations with disability outcomes, instead finding other loci. We...

Full description

Saved in:
Bibliographic Details
Published in:Brain communications Vol. 6; no. 6; p. fcae443
Main Authors: Sahi, Nitin, Haider, Lukas, Chung, Karen, Prados Carrasco, Ferran, Kanber, Baris, Samson, Rebecca, Thompson, Alan J, Trip, S Anand, Brownlee, Wallace, Ciccarelli, Olga, Barkhof, Frederik, Tur, Carmen, Houlden, Henry, Chard, Declan
Format: Journal Article
Language:English
Published: UK Oxford University Press 2024
Subjects:
severity
phenotype
genetics
disease progression
multiple sclerosis
ISSN:2632-1297, 2632-1297
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The first genome-wide significant multiple sclerosis severity locus, rs10191329, has been pathologically linked to cortical lesion load and brain atrophy. However, observational cohorts such as MSBase have not replicated associations with disability outcomes, instead finding other loci. We evaluated rs10191329 and MSBase loci in a unique cohort of 53 people followed for 30 years after a clinically isolated syndrome, with deep clinical phenotyping and MRI measures of inflammation and neurodegeneration. After 30 years, 26 had developed relapsing-remitting multiple sclerosis, 15 secondary progressive multiple sclerosis and 12 remained diagnosed with a clinically isolated syndrome. Genetic associations with disease severity (age-related multiple sclerosis severity score and Expanded Disability Status Scale), disease course and brain MRI features (white matter lesions, cortical lesions and grey matter fraction) were investigated using regression models and survival analyses. rs10191329 was not associated with multiple sclerosis severity, secondary progressive multiple sclerosis diagnosis or brain MRI features at 30 years. Similarly, MSBase loci were not associated with 30-year disease severity, although rs73091975 was significantly associated with lower 14-year age-related multiple sclerosis severity score in those developing multiple sclerosis. Given that effect sizes for both rs10191329 and rs73091975 were greatest between 14 and 20 years, these findings suggest genetic effects on multiple sclerosis severity may interact non-linearly with disease duration. Sahi et al. evaluated rs10191329 and MSBase genetic variants with multiple sclerosis severity 30 years after the first symptoms. No loci were associated with 30-year disability, MRI outcomes or disease course, although rs73091975 was associated with age-related multiple sclerosis severity at 14 years, suggesting potential for non-linear genetic effects over time. Graphical Abstract Graphical Abstract
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2632-1297
2632-1297
DOI:10.1093/braincomms/fcae443